Shell Asset Management CO Ginkgo Bioworks Holdings, Inc. Transaction History

Shell Asset Management CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jul 31, 2024	SELL	$1.06 - $1.67 $1,677 - $2,643	-1,583 Reduced 5.5%	27,177 $9,000
Q1 2024 May 14, 2024	SELL	$1.06 - $1.67 $261 - $412	-247 Reduced 0.85%	28,760 $33,000
Q4 2023 Feb 14, 2024	SELL	$1.26 - $1.79 $10,950 - $15,556	-8,691 Reduced 23.05%	29,007 $49,000
Q3 2023 Nov 08, 2023	SELL	$1.61 - $2.54 $953 - $1,503	-592 Reduced 1.55%	37,698 $68,000
Q2 2023 Jul 28, 2023	SELL	$1.14 - $1.95 $256 - $438	-225 Reduced 0.58%	38,290 $71,000
Q1 2023 May 15, 2023	SELL	$1.2 - $2.19 $160 - $293	-134 Reduced 0.35%	38,515 $51,000
Q4 2022 Feb 07, 2023	SELL	$1.63 - $3.52 $11,812 - $25,509	-7,247 Reduced 15.79%	38,649 $65,000
Q3 2022 Nov 14, 2022	SELL	$0.73 - $3.74 $8,834 - $45,261	-12,102 Reduced 20.87%	45,896 $143,000
Q2 2022 Aug 09, 2022	BUY	$2.2 - $4.2 $127,595 - $243,591	57,998 New	57,998 $138,000

48.4M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.25B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

Stay updated on Shell Asset Management CO with notifications on news.